I think scarring is a multi billion $ valuation on its own. Add the oncology valuation to it.
Personally, I would not be rushing to divest and focus on oncology.
And shareholders should demand that scarring remain in-house for as long as it is feasible.
Retail holders must be fully rewarded for every asset that they own via their SNT holding.
- Forums
- ASX - By Stock
- SNT
- Ann: Acceleration of skin scarring program
SNT
syntara limited
Add to My Watchlist
0.00%
!
6.3¢

Ann: Acceleration of skin scarring program, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.4M |
Open | High | Low | Value | Volume |
6.3¢ | 6.3¢ | 6.3¢ | $12.08K | 191.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 226979 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 429345 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 226979 | 0.062 |
1 | 200000 | 0.061 |
4 | 233331 | 0.060 |
3 | 94655 | 0.058 |
2 | 224770 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 14000 | 2 |
0.064 | 394997 | 1 |
0.065 | 624150 | 4 |
0.067 | 135766 | 2 |
0.068 | 1050000 | 2 |
Last trade - 10.03am 31/07/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |